Skip to search
Skip to main content
Back to Search
Start Over
Results from the phase 2 RESONATE (TM)-17 Trial: Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic leukaemia with 17p deletion
Authors :
Munir, T. O'Brien, S. Jones, J. A. Coutre, S. E. Mato, A. R. Hillmen, P. Tam, C. Osterborg, A. Siddiqi, T. Thirman, M. J. Furman, R. R. Ilhan, O. Keating, M. Call, T. G. Brown, J. R. Stevens-Brogan, M. Li, Y. Clow, F. James, D. Chu, A. Hallek, M. Stilgenbauer, S. Munir, T. O'Brien, S. Jones, J. A. Coutre, S. E. Mato, A. R. Hillmen, P. Tam, C. Osterborg, A. Siddiqi, T. Thirman, M. J. Furman, R. R. Ilhan, O. Keating, M. Call, T. G. Brown, J. R. Stevens-Brogan, M. Li, Y. Clow, F. James, D. Chu, A. Hallek, M. Stilgenbauer, S.
Publication Year :
2015
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1247371729
Document Type :
Electronic Resource